Humana AB
Humana AB (publ) provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark. It operates through three segments: Sweden, Finland, and Norway. The company provides care and treatment for psychosocial disorders, mental illness, and functional impairment; residential care homes; family care services; short-term, short term housing, day crare, and spe… Read more
Humana AB (0RF7) - Net Assets
Latest net assets as of March 2024: Skr2.98 Billion SEK
Based on the latest financial reports, Humana AB (0RF7) has net assets worth Skr2.98 Billion SEK as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr10.21 Billion) and total liabilities (Skr7.22 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr2.98 Billion |
| % of Total Assets | 29.24% |
| Annual Growth Rate | 15.01% |
| 5-Year Change | 26.84% |
| 10-Year Change | 196.65% |
| Growth Volatility | 15.68 |
Humana AB - Net Assets Trend (2012–2023)
This chart illustrates how Humana AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Humana AB (2012–2023)
The table below shows the annual net assets of Humana AB from 2012 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | Skr2.92 Billion | +6.79% |
| 2022-12-31 | Skr2.74 Billion | +7.29% |
| 2021-12-31 | Skr2.55 Billion | +8.45% |
| 2020-12-31 | Skr2.35 Billion | +2.08% |
| 2019-12-31 | Skr2.31 Billion | +7.41% |
| 2018-12-31 | Skr2.15 Billion | +13.54% |
| 2017-12-31 | Skr1.89 Billion | +9.56% |
| 2016-12-31 | Skr1.73 Billion | +57.91% |
| 2015-12-31 | Skr1.09 Billion | +10.85% |
| 2014-12-31 | Skr986.00 Million | +15.59% |
| 2013-12-31 | Skr853.00 Million | +35.72% |
| 2012-12-31 | Skr628.48 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Humana AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 181.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr1.77 Billion | 61.26% |
| Common Stock | Skr1.00 Million | 0.03% |
| Other Comprehensive Income | Skr21.00 Million | 0.73% |
| Other Components | Skr1.10 Billion | 37.98% |
| Total Equity | Skr2.89 Billion | 100.00% |
Humana AB Competitors by Market Cap
The table below lists competitors of Humana AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Toyo Kanetsu K.K
F:TQ2
|
$110.14 Million |
|
Onward Medical N.V.
BR:ONWD
|
$110.15 Million |
|
IM Vinaria Purcari SRL
RO:WINE
|
$110.16 Million |
|
Liton Technology
TWO:6175
|
$110.21 Million |
|
Humana AB (publ)
ST:HUM
|
$110.09 Million |
|
MMTEC Inc
NASDAQ:MTC
|
$110.07 Million |
|
Aurona Industries
TWO:8074
|
$110.06 Million |
|
Lim Seong Hai Capital Berhad
KLSE:0351
|
$110.05 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Humana AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 2,739,000,000 to 2,886,000,000, a change of 147,000,000 (5.4%).
- Net income of 176,000,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 29,000,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr176.00 Million | +6.1% |
| Other Comprehensive Income | Skr-29.00 Million | -1.0% |
| Total Change | Skr- | 5.37% |
Book Value vs Market Value Analysis
This analysis compares Humana AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.75x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.23x to 0.75x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | Skr13.97 | Skr45.05 | x |
| 2013-12-31 | Skr18.96 | Skr45.05 | x |
| 2014-12-31 | Skr21.51 | Skr45.05 | x |
| 2015-12-31 | Skr23.81 | Skr45.05 | x |
| 2016-12-31 | Skr33.50 | Skr45.05 | x |
| 2017-12-31 | Skr35.59 | Skr45.05 | x |
| 2018-12-31 | Skr40.08 | Skr45.05 | x |
| 2019-12-31 | Skr42.98 | Skr45.05 | x |
| 2020-12-31 | Skr44.42 | Skr45.05 | x |
| 2021-12-31 | Skr52.42 | Skr45.05 | x |
| 2022-12-31 | Skr57.11 | Skr45.05 | x |
| 2023-12-31 | Skr60.34 | Skr45.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Humana AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.10%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.82%
- • Asset Turnover: 0.96x
- • Equity Multiplier: 3.48x
- Recent ROE (6.10%) is below the historical average (8.40%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 7.00% | 1.47% | 1.72x | 2.76x | Skr-18.87 Million |
| 2013 | 13.01% | 3.18% | 1.59x | 2.57x | Skr25.70 Million |
| 2014 | 3.85% | 0.75% | 1.38x | 3.71x | Skr-60.60 Million |
| 2015 | 2.56% | 0.50% | 1.46x | 3.51x | Skr-81.30 Million |
| 2016 | 8.57% | 2.33% | 1.28x | 2.87x | Skr-24.60 Million |
| 2017 | 10.26% | 2.97% | 1.29x | 2.68x | Skr4.90 Million |
| 2018 | 11.55% | 3.66% | 1.29x | 2.45x | Skr33.00 Million |
| 2019 | 8.23% | 2.52% | 0.90x | 3.60x | Skr-40.40 Million |
| 2020 | 11.13% | 3.37% | 0.97x | 3.42x | Skr26.60 Million |
| 2021 | 10.81% | 3.37% | 0.91x | 3.53x | Skr20.70 Million |
| 2022 | 7.67% | 2.28% | 0.94x | 3.58x | Skr-63.90 Million |
| 2023 | 6.10% | 1.82% | 0.96x | 3.48x | Skr-112.60 Million |
Industry Comparison
This section compares Humana AB's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Humana AB (0RF7) | Skr2.98 Billion | 7.00% | 2.42x | $110.09 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |